Cellectis (CLLS) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free CLLS Stock Alerts $2.49 -0.01 (-0.40%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cellectis Short Interest DataCurrent Short Volume672,800 sharesPrevious Short Volume676,500 sharesChange Vs. Previous Month-0.55%Dollar Volume Sold Short$1.76 millionShort Interest Ratio / Days to Cover17.8Last Record DateApril 15, 2024Outstanding Shares55,580,000 sharesPercentage of Shares Shorted1.21%Today's Trading Volume14,710 sharesAverage Trading Volume40,396 sharesToday's Volume Vs. Average36% Short Selling Cellectis ? Sign up to receive the latest short interest report for Cellectis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCLLS Short Interest Over TimeCLLS Days to Cover Over TimeCLLS Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Cellectis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024672,800 shares $1.76 million -0.6%N/A17.8 $2.62 3/31/2024676,500 shares $1.79 million -0.4%N/A16.3 $2.65 3/15/2024679,300 shares $1.73 million -6.6%N/A13.5 $2.54 2/29/2024727,500 shares $1.88 million -0.1%N/A10.6 $2.58 2/15/2024728,200 shares $2.08 million -0.9%N/A8.2 $2.85 1/31/2024735,100 shares $2.21 million -4.2%N/A3.6 $3.00 Get the Latest News and Ratings for CLLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024767,300 shares $2.22 million -1.9%N/A0.4 $2.89 12/31/2023781,800 shares $2.41 million -7.0%N/A0.4 $3.08 12/15/2023840,900 shares $2.69 million -19.9%N/A0.5 $3.20 11/30/20231,050,000 shares $3.13 million -28.1%N/A0.6 $2.98 11/15/20231,460,000 shares $4.09 million +302.8%N/A0.8 $2.80 10/31/2023362,500 shares $349,450.00 -2.7%N/A0.2 $0.96 10/15/2023372,400 shares $513,912.00 +7.9%N/A6.9 $1.38 9/30/2023345,200 shares $545,416.00 +7.6%N/A5.6 $1.58 9/15/2023320,800 shares $545,360.00 -0.5%N/A6.3 $1.70 8/31/2023322,300 shares $667,161.00 -2.7%N/A6.5 $2.07 8/15/2023331,100 shares $652,267.00 -3.5%N/A6.5 $1.97 7/31/2023343,200 shares $734,448.00 +9.2%N/A5.7 $2.14 7/15/2023314,400 shares $704,287.44 +0.5%N/A5.5 $2.24 6/30/2023312,800 shares $615,434.00 -1.4%N/A6.2 $1.97 6/15/2023317,300 shares $640,946.00 +2.6%N/A5.2 $2.02 5/31/2023309,200 shares $587,480.00 -2.5%N/A4.5 $1.90 5/15/2023317,200 shares $558,272.00 +0.2%N/A4.6 $1.76 4/30/2023316,700 shares $595,396.00 -13.0%N/A3.7 $1.88 4/15/2023363,800 shares $742,152.00 -0.2%N/A3.2 $2.04 3/31/2023364,600 shares $703,678.00 -2.3%N/A2.8 $1.93 3/15/2023373,100 shares $682,773.00 +1.4%N/A2.7 $1.83 2/28/2023367,900 shares $813,059.00 -6.6%N/A2.5 $2.21 2/15/2023393,800 shares $945,120.00 +5.4%N/A2.6 $2.40 1/31/2023373,600 shares $1.14 million +34.6%N/A2.4 $3.05 1/15/2023277,600 shares $1.07 million +31.0%0.6%2.4 $3.84 12/30/2022211,900 shares $444,990.00 -32.2%0.5%1.9 $2.10 12/15/2022312,400 shares $702,900.00 -17.4%0.7%3.2 $2.25 11/30/2022378,000 shares $831,600.00 -28.2%0.8%4.5 $2.20 11/15/2022526,300 shares $1.18 million -9.3%1.2%6.3 $2.25 10/31/2022580,400 shares $1.44 million -13.9%1.3%6.9 $2.49 10/15/2022674,400 shares $1.66 million -6.7%1.5%6.5 $2.46 9/30/2022722,600 shares $1.65 million -11.8%1.6%6.6 $2.29 9/15/2022819,400 shares $2.61 million -2.4%1.8%7.2 $3.19 8/31/2022839,700 shares $2.78 million -2.4%1.9%6.5 $3.31“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). CLLS Short Interest - Frequently Asked Questions What is Cellectis' current short interest? Short interest is the volume of Cellectis shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 672,800 shares of CLLS short. Learn More on Cellectis' current short interest. What is a good short interest ratio for Cellectis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLLS shares currently have a short interest ratio of 18.0. Learn More on Cellectis's short interest ratio. Is Cellectis' short interest increasing or decreasing? Cellectis saw a decline in short interest in April. As of April 15th, there was short interest totaling 672,800 shares, a decline of 0.5% from the previous total of 676,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cellectis' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cellectis: Zura Bio Limited (2.27%), Molecular Partners AG (0.16%), DBV Technologies S.A. (0.27%), Agenus Inc. (13.01%), Vaxart, Inc. (10.37%), Omega Therapeutics, Inc. (21.69%), Scilex Holding (7.13%), Cardiol Therapeutics Inc. (0.42%), Genfit S.A. (0.19%), Compugen Ltd. (2.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Cellectis stock? Short selling CLLS is an investing strategy that aims to generate trading profit from Cellectis as its price is falling. CLLS shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cellectis? A short squeeze for Cellectis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLLS, which in turn drives the price of the stock up even further. How often is Cellectis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLLS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Zura Bio Short Interest Molecular Partners Short Interest DBV Technologies Short Interest Agenus Short Interest Vaxart Short Interest Omega Therapeutics Short Interest Scilex Short Interest Cardiol Therapeutics Short Interest Genfit Short Interest Compugen Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLLS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarnings